Skip to main content
Clinical Trials/NCT06864390
NCT06864390Not yet recruitingNot Applicable

Genicular Nerve Phenol Neurolysis Versus Radiofrequency Ablation for Pain Relief in Grade 4 Knee Osteoarthritis

Ain Shams University0 sites114 target enrollmentStarted: April 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
114
Primary Endpoint
Numeric rating scale

Study Overview

Brief Summary

The goal of this clinical trial is to compare the efficiency and efficacy of genicular nerves blockade by chemical phenol neurolysis versus radiofrequency ablation in managing pain in patients suffering from grade IV KOA in term of NRS pain score.

The participants will be evaluated by numeric rating scale and oxford knee score for assessment of pain relief up to 16 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Grade 4 knee osteoarthritis according to Kellgren-Lawrence radiological classification.
  • •Failure to manage pain with conservative methods.

Exclusion Criteria

  • •Prior knee replacement
  • •Patients with cardiac pacemakers or implantable cardiac defibrillators.
  • •Septic knee or systemic sepsis.
  • •Allergy to any of the drugs used in the study.
  • •Coagulopathy or patients on anticoagulants.
  • •Patients with psychiatric illness.

Arms & Interventions

genicular nerve phenol neurolysis

Experimental

chemical neurolysis using 2 mL of 9% phenol solution prepared from crystallized phenol will be applied to each genicular nerve.

Intervention: genicular nerve neurolysis (Procedure)

genicular nerve radiofrequency ablation

Experimental

Radiofrequency thermocoagulation will be applied to each nerve at 80 degrees for 90 seconds.

Intervention: genicular nerve neurolysis (Procedure)

Outcomes

Primary Outcomes

Numeric rating scale

Time Frame: baseline, 2, 4, 8,12 and 16 weeks after the procedure

By an independent physician pain will be recorded using numeric rating scale which is a screening tool used to assess pain severity using a 0 - 10 scale with zero meaning no pain and 10 meaning the worst pain ever.

Secondary Outcomes

  • oxford knee score(baseline, 4, 8, 12, 16 weeks after the procedure)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

Genicular Nerve Phenol Neurolysis Versus... | Clinical Trial